E. Pearson
Cancer Research · 2003–2021
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 11 citations into it
- Radiology, Nuclear Medicine and Imaging — 8 citations into it
Whom E. Pearson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from E. Pearson's perspective
Ordered by how strongly the researchers E. Pearson trusts endorse each paper. Same corpus, a different order for every researcher.
- Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. (Biochemical Journal)
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase (Nature)
- Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* (Journal of Biological Chemistry)
- A metagenome-wide association study of gut microbiota in type 2 diabetes (Nature)
- Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (Journal of Clinical Investigation)
- Metformin improves healthspan and lifespan in mice (Nature Communications)
- An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice (Gut)
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. (Journal of Clinical Investigation)
- Metformin: An Update (Annals of Internal Medicine)
Their papers
- Metformin and the gastrointestinal tract (2016) — 658 citations
- The mechanisms of action of metformin (2017) — 2,013 citations
- Genetic cause of hyperglycaemia and response to treatment in diabetes. (2003) — 594 citations
- Using machine learning approaches for multi-omics data analysis: A review. (2021) — 714 citations
- Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. (2006) — 967 citations
- Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. (2004) — 1,162 citations